PT Indofarma Tbk (ISX:INAF) Total Stockholders Equity : Rp-105,341 Mil (As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Total Stockholders Equity?

PT Indofarma Tbk's Total Stockholders Equity for the quarter that ended in Sep. 2023 was Rp-105,341 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PT Indofarma Tbk's Book Value per Share for the quarter that ended in Sep. 2023 was Rp-33.99. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PT Indofarma Tbk's Debt-to-Equity for the quarter that ended in Sep. 2023 was -7.33.

PT Indofarma Tbk Total Stockholders Equity Historical Data

The historical data trend for PT Indofarma Tbk's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Total Stockholders Equity Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

496,646.17

504,933.64

430,321.80

508,295.78

86,359.13

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															325,185.59	86,359.13	24,562.63	-33,986.91	-105,340.76

PT Indofarma Tbk (ISX:INAF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PT Indofarma Tbk's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-105340.763	-	0)	/	3099.27
	=	-33.99

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PT Indofarma Tbk's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(355862.53	+	415861.828)	/	-105340.763
	=	-7.33

PT Indofarma Tbk Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines